Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
addressing, Adelaide, African, arbitration, article, back, Binomial, Black, block, blurred, Cataract, Chiltern, chosen, compelling, concerted, conference, consecutive, conserving, constructive, Continence, customer, David, Deferral, deposit, depressed, disability, Distinguishing, Eastern, edition, EKC, endpoint, Engineering, Eurozone, fifteen, Foundation, fundamental, gradually, Greek, highlighted, Hoon, impede, instrumental, invite, issuable, jeopardize, joined, Lattice, leadership, led, lieu, Macau, mainland, Middle, Mimicking, OAB, optimal, OUM, oversee, pace, Pioneer, placebo, post, poster, pre, preliminary, Professor, promising, properly, pure, put, Refractive, renegotiate, resolution, reverted, Rhinologic, Roy, Russell, SAWC, sheep, Simon, Stroman, subset, suited, Surgery, Symbio, Symposium, theme, titled, Today, Treasurer, uncovered, underway, unmet, unsatisfactory, USA, vacation, veterinary, Virbac, vision, won, Wormald, worth, Wu
Removed:
accelerated, accuracy, allocated, analog, antimicrobial, bacterium, bloodstream, borrowing, catheterization, CAUTI, commitment, conform, consolidate, creating, creation, dated, dermal, destroy, dosing, duration, enhanced, expired, exploring, extremely, field, fungal, heightened, impaired, inflamed, institution, intensive, invading, invented, investor, KCI, Kinetic, marketplace, naturally, NCT, nose, notified, penalty, penetrate, penetration, platform, PM, reclassified, reliability, repaid, reversed, revision, routine, secured, stable, Toronto, TSX, Underwriter, unqualified
Filing tables
Filing exhibits
NBY similar filings
Filing view
External links
Exhibit 23.1
We consent to the incorporation by reference in Registration Statements on S-8 (333-147334, 333-157041, 333-164469, and 333-171981) and on Form S-3 (333-159917) of our report dated March 26, 2012, with respect to the consolidated financial statements of NovaBay Pharmaceuticals, Inc. included in its Annual Report on Form 10-K for the year ended December 31, 2011.
/S/ OUM & Co. LLP
San Francisco, CaliforniaMarch 26, 2012